BiotechTube

AUTO4

Phase 1/2Terminated
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

T Cell Non-Hodgkin Lymphoma

Conditions

T Cell Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma, Anaplastic Large Cell Lymphoma

Trial Timeline

Aug 30, 2018 → Dec 12, 2024

NCT ID
NCT03590574

About AUTO4

AUTO4 is a phase 1/2 stage product being developed by Autolus Therapeutics for T Cell Non-Hodgkin Lymphoma. The current trial status is terminated. This product is registered under clinical trial identifier NCT03590574. Target conditions include T Cell Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma.

Hype Score Breakdown

Clinical
13
Activity
8
Company
2
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT03590574Phase 1/2Terminated

Competing Products

20 competing products in T Cell Non-Hodgkin Lymphoma

See all competitors
ProductCompanyStageHype Score
AFM24 + SNK01AffimedPhase 1/2
33
Sintilimab + Nab paclitaxel + CisplatinCSPC Pharmaceutical Group LimitedPhase 2
51
Mitoxantrone hydrochloride liposome Injection-based bridging therapy+ Fludarabine-based chemotherapy +CD19 CAR-T CellsCSPC Pharmaceutical Group LimitedPhase 2
51
prednisoneKiniksa PharmaceuticalsPhase 2
47
BBP-398 with nivolumabBridgeBio PharmaPhase 1
30
Pemetrexed + CarboplatinEli LillyPhase 3
77
Necitumumab + Gemcitabine + CarboplatinEli LillyPhase 2
52
SelpercatinibEli LillyPre-clinical
23
Pemetrexed + Cisplatin + Placebo + PemetrexedEli LillyPhase 3
77
NBTXR3NanobiotixPhase 1/2
36
Cemiplimab + CetuximabEli LillyPhase 2
52
PemetrexedEli LillyPre-clinical
23
pemetrexed + erlotinibEli LillyPhase 2
52
Necitumumab-Gemcitabine-CisplatinEli LillyPhase 2
52
LY3295668 ErbumineEli LillyPhase 1
33
CT-01 + EVEROLIMUSCaptor TherapeuticsPhase 1
25
BB-401Benitec BiopharmaPhase 2
44
FYB206 + FYB206 + KeytrudaFormycon AGPhase 3
69
6-Thio-2'-Deoxyguanosine + CemiplimabMAIA BiotechnologyPhase 2
44
6-Thio-2'-Deoxyguanosine + Cemiplimab + Docetaxel + Vinorelbine + Gemcitabine aloneMAIA BiotechnologyPhase 3
69

Other Products from Autolus Therapeutics

AUTO CAR T cell therapyPhase 2
44
Obecabtagene autoleucelPhase 2
44
Obecabtagene autoleucelPhase 2
44
Obecabtagene AutoleucelPhase 2
44
AUTO3Phase 1/2
33